oral ghk-cu dosage Dosage: Clinical Guidance for Safe Administration – PlexusDx GHK-CU aka the beauty peptide.

Patients with autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, and T1D, have been shown to have lower levels of CTLA4 mRNA (85)

The diagnosis is established by: Low activity of -glutamyl transpeptidase in nucleated cells such as leukocytes or cultured skin fibroblasts

BPC-157 supports this function by modulating inflammatory pathways, promoting microvascular regeneration, and accelerating epithelial turnover

A compound that can specifically target and eliminate these harmful cells

Copper accumulation also becomes a theoretical concern at extreme doses, though practical protocols stay well below problematic thresholds